Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I Study of Pomalidomide and Nivolumab in Patients With Virus-Associated Malignancies With or Without HIV

Next Previous
X
Search
Trial Profile

A Phase I Study of Pomalidomide and Nivolumab in Patients With Virus-Associated Malignancies With or Without HIV

Status: Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nivolumab (Primary) ; Pomalidomide (Primary) ; Aspirin
  • Indications Anal cancer; Cervical cancer; Gastric cancer; Head and neck cancer; Hodgkin's disease; Kaposi's sarcoma; Leiomyosarcoma; Liver cancer; Lymphoma; Merkel cell carcinoma; Nasopharyngeal cancer; Non-Hodgkin's lymphoma; Penile cancer; Primary-Effusion-Lymphoma; Vulvovaginal cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 10 Dec 2021 Planned initiation date (estimated date for recruitment of the first subject) changed to 16 Dec 2021.
    • 26 Nov 2021 Planned initiation date (estimated date for recruitment of the first subject) changed from 30 Nov 2021 to 2 Dec 2021.
    • 24 Nov 2021 Planned initiation date (estimated date for recruitment of the first subject) changed to 30 Nov 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top